✦ LIBER ✦

Detecting minimal residual disease in patients with chronic lymphocytic leukemia using 8-color flow cytometry protocol in routine hematological practice

✍ Scribed by Stehlíková, O.; Chovancová, J.; Tichý, B.; Krejčí, M.; Brychtová, Y.; Panovská, A.; Francová Skuhrová, H.; Burčková, K.; Borský, M.; Loja, T.; Mayer, J.; Pospíšilová, Š.; Doubek, M.

Book ID: 121186823
Publisher: John Wiley and Sons
Year: 2013
Tongue: English
Weight: 190 KB
Volume: 36
Category: Article
ISSN: 1751-5521
DOI: 10.1111/ijlh.12149

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A single tube 10-color flow cytometry as

A single tube 10-color flow cytometry assay optimizes detection of minimal residual disease in chronic lymphocytic leukemia

✍ Sartor, M. M.; Gottlieb, D. J. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 419 KB

Stem cell transplantation in poor-risk c

Stem cell transplantation in poor-risk chronic lymphocytic leukemia: assessment of post-transplant minimal residual disease using four- and six-color flow cytometry and allele-specific RQ-PCR

✍ Maija Itälä; Anna-Riina Huhtinen; Vesa Juvonen; Veli Kairisto; Tarja-Terttu Pell 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 233 KB

The use of receiver operating characteri

The use of receiver operating characteristic analysis for detection of minimal residual disease using five-color multiparameter flow cytometry in acute myeloid leukemia identifies patients with high risk of relapse

✍ Adhra Al-Mawali; David Gillis; Ian Lewis 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 461 KB 👁 2 views

## Abstract ## Background: Multiparameter flow cytometry (MFC) has been shown to be a useful approach for detection of minimal residual disease (MRD). The aim of the study was to determine the optimal threshold that can separate patients into two groups in terms of leukemic residual cells and rela

5.38 Interest of Early Determination of

5.38 Interest of Early Determination of Bone Marrow Minimal Residual Disease by a Sensitive 6-Color Flow Cytometry in the Evaluation of Response: the Experience of the CLL2007FMP, an Intergroup Phase III Randomized Multicentric Trial Comparing Fludarabine, Cyclophosphamide, and Rituximab versus Fludarabine, Cyclophosphamide, and MabCampath in Previously Untreated B-Chronic Lymphocytic Leukemia Patients

✍ Remi Letestu; Stephane Leprêtre; Christine Arnoulet; Lucille Baseggio; Lydia Cam 📂 Article 📅 2011 🏛 Elsevier 🌐 English ⚖ 81 KB